Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,815
archived clinical trials in
Parkinsons Disease

A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
USC, Keck School of Medicine
1970
mi
from 43215
Los Angeles, CA
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
USC, Keck School of Medicine
1970
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
SC3 Research Group, Inc
1964
mi
from 43215
Pasadena, CA
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
SC3 Research Group, Inc
1964
mi
from 43215
Pasadena, CA
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
JEM Research Institute
939
mi
from 43215
Atlantis, FL
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
JEM Research Institute
939
mi
from 43215
Atlantis, FL
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Aventura Neurologic Associates
981
mi
from 43215
Aventura, FL
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Aventura Neurologic Associates
981
mi
from 43215
Aventura, FL
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Parkinson's Disease and Movement Disorders Center of Boca Raton
955
mi
from 43215
Boca Raton, FL
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Parkinson's Disease and Movement Disorders Center of Boca Raton
955
mi
from 43215
Boca Raton, FL
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Neurology Associates, PA
788
mi
from 43215
Maitland, FL
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Neurology Associates, PA
788
mi
from 43215
Maitland, FL
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Neurology Associates of Ormond Beach
747
mi
from 43215
Ormond Beach, FL
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Neurology Associates of Ormond Beach
747
mi
from 43215
Ormond Beach, FL
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Parkinson's Disease Treatment Center of SW Florida
899
mi
from 43215
Port Charlotte, FL
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Parkinson's Disease Treatment Center of SW Florida
899
mi
from 43215
Port Charlotte, FL
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Infinity Clinical Research, LLC
965
mi
from 43215
Sunrise, FL
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Infinity Clinical Research, LLC
965
mi
from 43215
Sunrise, FL
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Hawaii Pacific Neuroscience
4501
mi
from 43215
Honolulu, HI
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Hawaii Pacific Neuroscience
4501
mi
from 43215
Honolulu, HI
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Unity Point Health
574
mi
from 43215
Des Moines, IA
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Unity Point Health
574
mi
from 43215
Des Moines, IA
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
University of Kansas Medical Center
627
mi
from 43215
Kansas City, KA
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
University of Kansas Medical Center
627
mi
from 43215
Kansas City, KA
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
University of Kentucky, Department of Neurology
155
mi
from 43215
Lexington, KY
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
University of Kentucky, Department of Neurology
155
mi
from 43215
Lexington, KY
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Henry Ford West Bloomfield Hospital
178
mi
from 43215
Bloomfield Hills, MI
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Henry Ford West Bloomfield Hospital
178
mi
from 43215
Bloomfield Hills, MI
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Struthers Parkinson's Center
630
mi
from 43215
Golden Valley, MN
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Struthers Parkinson's Center
630
mi
from 43215
Golden Valley, MN
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
The Robert and John M. Bendheim Parkinson and Movement Disorders Center
480
mi
from 43215
New York, NY
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
The Robert and John M. Bendheim Parkinson and Movement Disorders Center
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Asheville Neurology Specialists, PA
304
mi
from 43215
Asheville, NC
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Asheville Neurology Specialists, PA
304
mi
from 43215
Asheville, NC
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Raleigh Neurology Associates
371
mi
from 43215
Raleigh, NC
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Raleigh Neurology Associates
371
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Movement Disorders Clinic of Oklahoma
751
mi
from 43215
Tulsa, OK
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Movement Disorders Clinic of Oklahoma
751
mi
from 43215
Tulsa, OK
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Abington Neurological Associates
418
mi
from 43215
Willow Grove, PA
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Abington Neurological Associates
418
mi
from 43215
Willow Grove, PA
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Baylor College of Medicine
991
mi
from 43215
Houston, TX
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
University of Virginia, Department of Neurology
277
mi
from 43215
Charlottesville, VA
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
University of Virginia, Department of Neurology
277
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Booth Gardner Parkinson's Care Center
2000
mi
from 43215
Kirkland, WA
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Booth Gardner Parkinson's Care Center
2000
mi
from 43215
Kirkland, WA
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Premier Clinical Research
1779
mi
from 43215
Spokane, WA
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Premier Clinical Research
1779
mi
from 43215
Spokane, WA
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
University of Wisconsin-Madison
394
mi
from 43215
Madison, WI
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
University of Wisconsin-Madison
394
mi
from 43215
Madison, WI
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Ottawa Hospital Research Institute
526
mi
from 43215
Ottawa,
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Ottawa Hospital Research Institute
526
mi
from 43215
Ottawa,
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
University of Arkansas for Medical Sciences
624
mi
from 43215
Little Rock, AR
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
University of Arkansas for Medical Sciences
624
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated:  1/17/2018
Collaborative Neuroscience Network, Inc.
1975
mi
from 43215
Long Beach, CA
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off"
Status: Enrolling
Updated: 1/17/2018
Collaborative Neuroscience Network, Inc.
1975
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
Local Fields Potentials Recorded From Deep Brain Stimulating Electrodes
Local Field Potentials Recorded From Deep Brain Stimulating Electrodes Implanted for the Treatment of Parkinson's Disease, Essential Tremor or Dystonia
Status: Enrolling
Updated:  1/18/2018
University of Colorado Hospital
1153
mi
from 43215
Aurora, CO
Local Fields Potentials Recorded From Deep Brain Stimulating Electrodes
Local Field Potentials Recorded From Deep Brain Stimulating Electrodes Implanted for the Treatment of Parkinson's Disease, Essential Tremor or Dystonia
Status: Enrolling
Updated: 1/18/2018
University of Colorado Hospital
1153
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Neural Signatures of Parkinson's Disease
Neural Signatures of Tremor, Bradykinesia and Freezing in the Subthalamic Region on Parkinson's Disease and Their Acute and Long-Term Modulation by Subthalamic Deep Brain Stimulation.
Status: Enrolling
Updated:  1/22/2018
Stanford Univ Med Ctr
2101
mi
from 43215
Stanford, CA
Neural Signatures of Parkinson's Disease
Neural Signatures of Tremor, Bradykinesia and Freezing in the Subthalamic Region on Parkinson's Disease and Their Acute and Long-Term Modulation by Subthalamic Deep Brain Stimulation.
Status: Enrolling
Updated: 1/22/2018
Stanford Univ Med Ctr
2101
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
Vibrotactile Stimulation in Parkinson's Disease
Vibrotactile Stimulation in Parkinson's Disease
Status: Enrolling
Updated:  1/22/2018
Stanford Movement Disorders Clinic
2101
mi
from 43215
Stanford, CA
Vibrotactile Stimulation in Parkinson's Disease
Vibrotactile Stimulation in Parkinson's Disease
Status: Enrolling
Updated: 1/22/2018
Stanford Movement Disorders Clinic
2101
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
DNS-7801 vs. Placebo in Parkinson's Disease
A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations
Status: Enrolling
Updated:  1/30/2018
Quest Research Institute
176
mi
from 43215
Farmington, MI
DNS-7801 vs. Placebo in Parkinson's Disease
A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations
Status: Enrolling
Updated: 1/30/2018
Quest Research Institute
176
mi
from 43215
Farmington, MI
Click here to add this to my saved trials
DNS-7801 vs. Placebo in Parkinson's Disease
A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations
Status: Enrolling
Updated:  1/30/2018
Collaborative Neuroscience Network, Inc.
1975
mi
from 43215
Long Beach, CA
DNS-7801 vs. Placebo in Parkinson's Disease
A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations
Status: Enrolling
Updated: 1/30/2018
Collaborative Neuroscience Network, Inc.
1975
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
DNS-7801 vs. Placebo in Parkinson's Disease
A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations
Status: Enrolling
Updated:  1/30/2018
SC3 Research
1964
mi
from 43215
Pasadena, CA
DNS-7801 vs. Placebo in Parkinson's Disease
A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations
Status: Enrolling
Updated: 1/30/2018
SC3 Research
1964
mi
from 43215
Pasadena, CA
Click here to add this to my saved trials
DNS-7801 vs. Placebo in Parkinson's Disease
A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations
Status: Enrolling
Updated:  1/30/2018
Rocky Mountain Movement Disorders Center
1162
mi
from 43215
Englewood, CO
DNS-7801 vs. Placebo in Parkinson's Disease
A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations
Status: Enrolling
Updated: 1/30/2018
Rocky Mountain Movement Disorders Center
1162
mi
from 43215
Englewood, CO
Click here to add this to my saved trials
DNS-7801 vs. Placebo in Parkinson's Disease
A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations
Status: Enrolling
Updated:  1/30/2018
Parkinson's Disease and Movement Disorders Center of Boca Raton
955
mi
from 43215
Boca Raton, FL
DNS-7801 vs. Placebo in Parkinson's Disease
A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations
Status: Enrolling
Updated: 1/30/2018
Parkinson's Disease and Movement Disorders Center of Boca Raton
955
mi
from 43215
Boca Raton, FL
Click here to add this to my saved trials
DNS-7801 vs. Placebo in Parkinson's Disease
A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations
Status: Enrolling
Updated:  1/30/2018
University of South Florida, Parkinson's Disease and Movement Disorders Center
830
mi
from 43215
Tampa, FL
DNS-7801 vs. Placebo in Parkinson's Disease
A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations
Status: Enrolling
Updated: 1/30/2018
University of South Florida, Parkinson's Disease and Movement Disorders Center
830
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
DNS-7801 vs. Placebo in Parkinson's Disease
A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations
Status: Enrolling
Updated:  1/30/2018
Washington University
398
mi
from 43215
Saint Louis, MO
DNS-7801 vs. Placebo in Parkinson's Disease
A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations
Status: Enrolling
Updated: 1/30/2018
Washington University
398
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
DNS-7801 vs. Placebo in Parkinson's Disease
A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations
Status: Enrolling
Updated:  1/30/2018
The Neurological Institute
348
mi
from 43215
Charlotte, NC
DNS-7801 vs. Placebo in Parkinson's Disease
A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations
Status: Enrolling
Updated: 1/30/2018
The Neurological Institute
348
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
DNS-7801 vs. Placebo in Parkinson's Disease
A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations
Status: Enrolling
Updated:  1/30/2018
Premier Clinical Research
1779
mi
from 43215
Spokane, WA
DNS-7801 vs. Placebo in Parkinson's Disease
A Phase 2a, Double-Blind, Placebo-Controlled Two-Part Study To Investigate the Safety and Efficacy of Increasing Doses Of DNS-7801 In Parkinson's Disease (PD) Subjects With Motor Fluctuations
Status: Enrolling
Updated: 1/30/2018
Premier Clinical Research
1779
mi
from 43215
Spokane, WA
Click here to add this to my saved trials
Detecting Dopaminergic Deficits in Individuals At-risk for Parkinsonism
Detecting Dopaminergic Deficits in Individuals At-risk for Parkinsonism
Status: Enrolling
Updated:  2/9/2018
University of Minnesota, Center for Magnetic Resonance Research
625
mi
from 43215
Minneapolis, MN
Detecting Dopaminergic Deficits in Individuals At-risk for Parkinsonism
Detecting Dopaminergic Deficits in Individuals At-risk for Parkinsonism
Status: Enrolling
Updated: 2/9/2018
University of Minnesota, Center for Magnetic Resonance Research
625
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Kinesia 360 Parkinson's Monitoring Study
Kinesia 360 Multi-Center Parkinson's Monitoring Study
Status: Enrolling
Updated:  2/15/2018
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Kinesia 360 Parkinson's Monitoring Study
Kinesia 360 Multi-Center Parkinson's Monitoring Study
Status: Enrolling
Updated: 2/15/2018
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Kinesia 360 Parkinson's Monitoring Study
Kinesia 360 Multi-Center Parkinson's Monitoring Study
Status: Enrolling
Updated:  2/15/2018
University of Rochester
354
mi
from 43215
Rochester, NY
Kinesia 360 Parkinson's Monitoring Study
Kinesia 360 Multi-Center Parkinson's Monitoring Study
Status: Enrolling
Updated: 2/15/2018
University of Rochester
354
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Kinesia 360 Parkinson's Monitoring Study
Kinesia 360 Multi-Center Parkinson's Monitoring Study
Status: Enrolling
Updated:  2/15/2018
Greenville Health System
357
mi
from 43215
Greenville, SC
Kinesia 360 Parkinson's Monitoring Study
Kinesia 360 Multi-Center Parkinson's Monitoring Study
Status: Enrolling
Updated: 2/15/2018
Greenville Health System
357
mi
from 43215
Greenville, SC
Click here to add this to my saved trials
Kinesia 360 Parkinson's Monitoring Study
Kinesia 360 Multi-Center Parkinson's Monitoring Study
Status: Enrolling
Updated:  2/15/2018
Cleveland Clinic
129
mi
from 43215
Cleveland, OH
Kinesia 360 Parkinson's Monitoring Study
Kinesia 360 Multi-Center Parkinson's Monitoring Study
Status: Enrolling
Updated: 2/15/2018
Cleveland Clinic
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Amitiza in Constipation Associated With PD (Parkinson's Disease)
Randomized Double-Blind Placebo-Controlled Trial of Lubiprostone in the Treatment of Constipation Associated With Parkinson's Disease
Status: Enrolling
Updated:  2/19/2018
University of South Florida
822
mi
from 43215
Tampa, FL
Amitiza in Constipation Associated With PD (Parkinson's Disease)
Randomized Double-Blind Placebo-Controlled Trial of Lubiprostone in the Treatment of Constipation Associated With Parkinson's Disease
Status: Enrolling
Updated: 2/19/2018
University of South Florida
822
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Amitiza in Constipation Associated With PD (Parkinson's Disease)
Randomized Double-Blind Placebo-Controlled Trial of Lubiprostone in the Treatment of Constipation Associated With Parkinson's Disease
Status: Enrolling
Updated:  2/19/2018
Baylor College of Medicine PDCMDC
995
mi
from 43215
Houston, TX
Amitiza in Constipation Associated With PD (Parkinson's Disease)
Randomized Double-Blind Placebo-Controlled Trial of Lubiprostone in the Treatment of Constipation Associated With Parkinson's Disease
Status: Enrolling
Updated: 2/19/2018
Baylor College of Medicine PDCMDC
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
The Impact of Standard Medical Care (Dopamine) and Practice on Postural Motor Learning in Parkinson's Disease
The Impact of Standard Medical Care (Dopamine) and Practice on Postural Motor Learning in Parkinson's Disease
Status: Enrolling
Updated:  2/19/2018
University of Utah
1511
mi
from 43215
Salt Lake City, UT
The Impact of Standard Medical Care (Dopamine) and Practice on Postural Motor Learning in Parkinson's Disease
The Impact of Standard Medical Care (Dopamine) and Practice on Postural Motor Learning in Parkinson's Disease
Status: Enrolling
Updated: 2/19/2018
University of Utah
1511
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Exogenous Effects of Standard Medical Care (Dopamine) on Motor Learning of an Upper Limb Task in Parkinson Disease
Exogenous Effects of Standard Medical Care (Dopamine) on Motor Learning of an Upper Limb Task in Parkinson Disease
Status: Enrolling
Updated:  2/20/2018
University of Utah
1511
mi
from 43215
Salt Lake City, UT
Exogenous Effects of Standard Medical Care (Dopamine) on Motor Learning of an Upper Limb Task in Parkinson Disease
Exogenous Effects of Standard Medical Care (Dopamine) on Motor Learning of an Upper Limb Task in Parkinson Disease
Status: Enrolling
Updated: 2/20/2018
University of Utah
1511
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease
A Double-Blind, Placebo-Controlled, Cross-Over Study of Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease
Status: Enrolling
Updated:  3/5/2018
Loma Linda University
1919
mi
from 43215
Loma Linda, CA
Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease
A Double-Blind, Placebo-Controlled, Cross-Over Study of Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease
Status: Enrolling
Updated: 3/5/2018
Loma Linda University
1919
mi
from 43215
Loma Linda, CA
Click here to add this to my saved trials